Comparative effectiveness of HMA with venetoclax vs intensive chemotherapy in AML with very high-risk cytogenetics
Luis E. Aguirre, Jan Philipp Bewersdorf, Y. Liu, Rory M. Shallis et autres
us, lt, fr (code pays fourni par la source)
4 citations
Blood Neoplasia